The US pathogen reduction system market is expanding as blood banks and healthcare providers increasingly prioritize the safety of blood components and transfusion practices. Growing concerns regarding transfusion-transmitted infections, along with increasing adoption of technologies designed to reduce pathogens in plasma, platelets, and other blood products, are supporting market demand....